Turning Alberta Oats into Global Bioactive Innovation

Every grain of oats hides molecules that can hydrate skin, soothe irritation, and support heart health. For decades, Ceapro Inc. has been unlocking that potential — transforming a humble Prairie crop into high-value active ingredients used by personal care and health brands around the world.

Headquartered in Edmonton and the core natural-products business of Cosciens Biopharma Inc. (TSX: CSCI), Ceapro develops, manufactures, and commercializes plant-derived bioactive ingredients using proprietary extraction and processing technologies. Our objective is straightforward: combine the simplicity of nature with the power of science to deliver ingredients that are clinically meaningful and sustainably sourced.

At the heart of our portfolio are four oat-derived actives — oat beta glucan, avenanthramides, oat oil, and oat flour — supported by our patented Pressurized Gas eXpanded (PGX) technology, a green processing platform that creates novel powders and delivery systems from natural polymers. Our flagship oat beta glucan is prized as an anti-aging active that deeply hydrates skin, with additional recognized benefits for cholesterol and blood-sugar management. Ceapro ingredients carry ECOCERT natural registration and are GMO-free, allergen-free, and never tested on animals.

Sharpening our focus

In 2026, Ceapro repositioned as a pure-play natural-based products company, concentrating on the strengths that global customers value most. By streamlining operations and tightening our cost structure, we have built a leaner, more disciplined business squarely focused on growing our core ingredient franchise.

Grounded in science

What sets Ceapro apart is a portfolio built on genuine science. Our green PGX platform and decades of extraction expertise let us deliver natural actives with performance that formulators can measure — from oat beta glucan’s proven skin hydration to the antioxidant strength of oat oil. As global brands move toward clean-label, sustainably sourced ingredients, that pairing of natural origin and rigorous science keeps Ceapro’s oat actives in steady demand across personal care and health markets worldwide.

Recent momentum

Early 2026 brought year-over-year revenue growth, reflecting renewed commercial traction across our personal care and health accounts. With more than two decades of manufacturing expertise, a loyal international customer base, and a portfolio grounded in real science, Ceapro remains a proudly Alberta-built leader in the global bioactives space.

Let’s connect

Whether you are a formulator seeking a differentiated natural active or a partner exploring what oats can do, we would love to hear from you. Learn more at ceapro.com and follow Cosciens Biopharma on LinkedIn.